egtazic acid has been researched along with quinpirole in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (50.00) | 18.2507 |
2000's | 4 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Natsukari, N; Weiss, B; Zhang, SP; Zhou, LW | 1 |
Bonanno, G; Fassio, A; Fontana, G; Marchi, M; Raiteri, M; Usai, C | 1 |
Greengard, P; Nishi, A; Snyder, GL | 1 |
Blond, O; Crépel, F; Desce, JM; Otani, S | 1 |
Dong, Y; Hu, XT; White, FJ; Zhang, XF | 1 |
Han, HJ; Heo, JS; Lee, MY | 1 |
Jomphe, C; Kobayashi, K; Lemelin, PL; Okano, H; Trudeau, LE | 1 |
Ford, CP; Phillips, PE; Williams, JT | 1 |
8 other study(ies) available for egtazic acid and quinpirole
Article | Year |
---|---|
Continuously infusing quinpirole decreases Ca2+/calmodulin-dependent phosphorylation in mouse striatum.
Topics: Animals; Calcium; Calcium-Calmodulin-Dependent Protein Kinases; Calmodulin; Calmodulin-Binding Proteins; Corpus Striatum; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Egtazic Acid; Electrophoresis, Polyacrylamide Gel; Ergolines; Infusions, Parenteral; Kinetics; Male; Mice; Molecular Weight; Nerve Tissue Proteins; Phosphoproteins; Phosphorylation; Quinpirole; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1993 |
Role of external and internal calcium on heterocarrier-mediated transmitter release.
Topics: Acetylcholine; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Calcium; Carrier Proteins; Chelating Agents; Choline; Clonidine; Dopamine; Dopamine Agonists; Egtazic Acid; Ergolines; GABA Modulators; Hippocampus; Male; Muscarinic Agonists; Neostriatum; Neuromuscular Depolarizing Agents; Neurons; Neurotransmitter Agents; Norepinephrine; Oxotremorine; Piperidines; Presynaptic Terminals; Quinpirole; Rats; Rats, Sprague-Dawley; Synaptosomes; Tritium; Yohimbine | 1996 |
Bidirectional regulation of DARPP-32 phosphorylation by dopamine.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Antipsychotic Agents; Calcineurin; Calcineurin Inhibitors; Calcium; Chelating Agents; Colforsin; Corpus Striatum; Cyclosporine; Dopamine; Dopamine Agonists; Dopamine and cAMP-Regulated Phosphoprotein 32; Egtazic Acid; Fenoldopam; Male; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Neurotoxins; Nucleus Accumbens; Phosphoproteins; Phosphorylation; Protein Processing, Post-Translational; Quinpirole; Raclopride; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate; Salicylamides; Signal Transduction; Tetrodotoxin | 1997 |
Dopamine facilitates long-term depression of glutamatergic transmission in rat prefrontal cortex.
Topics: 2-Amino-5-phosphonovalerate; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Calcium; Chelating Agents; Dopamine; Dopamine Agonists; Dopamine Antagonists; Egtazic Acid; Excitatory Amino Acid Antagonists; Glutamic Acid; Long-Term Potentiation; Male; Membrane Potentials; Neuronal Plasticity; Prefrontal Cortex; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate; Sulpiride; Synaptic Membranes; Synaptic Transmission | 1998 |
Dopamine D2 receptor-activated Ca2+ signaling modulates voltage-sensitive sodium currents in rat nucleus accumbens neurons.
Topics: Animals; Atropine; Calcium; Calcium Channel Blockers; Calcium Signaling; Chelating Agents; Cyclic AMP; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Egtazic Acid; Electric Stimulation; Enzyme Inhibitors; In Vitro Techniques; Male; Membrane Potentials; Models, Neurological; Muscarine; Muscarinic Antagonists; Neurons; Nucleus Accumbens; Parasympathomimetics; Patch-Clamp Techniques; Pertussis Toxin; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Salicylamides; Sodium Channels; Thionucleotides | 2005 |
Dopamine regulates cell cycle regulatory proteins via cAMP, Ca(2+)/PKC, MAPKs, and NF-kappaB in mouse embryonic stem cells.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenine; Animals; Calcium; Calcium Channel Blockers; Chelating Agents; DNA; Dopamine; Dose-Response Relationship, Drug; Egtazic Acid; MAP Kinase Signaling System; Mice; Neomycin; NF-kappa B; Nifedipine; Protein Kinase C; Quinpirole; Receptors, Dopamine D1; Receptors, Dopamine D2; Stem Cells; Thymidine; Time Factors | 2006 |
Bidirectional regulation of dopamine D2 and neurotensin NTS1 receptors in dopamine neurons.
Topics: Action Potentials; Animals; Calcium; Cells, Cultured; Chelating Agents; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Egtazic Acid; Green Fluorescent Proteins; Immunohistochemistry; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neurons; Neurotensin; Patch-Clamp Techniques; Peptide Fragments; Protein Kinase C; Pyrazoles; Quinolines; Quinpirole; Receptors, Dopamine D2; Receptors, Neurotensin; Sulpiride; Tyrosine 3-Monooxygenase | 2006 |
The time course of dopamine transmission in the ventral tegmental area.
Topics: Animals; Biophysics; Chelating Agents; Dizocilpine Maleate; Dopamine; Dopamine Agonists; Egtazic Acid; Electric Stimulation; Electrochemistry; Excitatory Amino Acid Antagonists; Female; G Protein-Coupled Inwardly-Rectifying Potassium Channels; GABA Antagonists; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Male; Mice; Mice, Inbred DBA; Neurons; Patch-Clamp Techniques; Phosphinic Acids; Picrotoxin; Propanolamines; Quinoxalines; Quinpirole; Rhodamines; Signal Transduction; Statistics, Nonparametric; Temperature; Time Factors; Ventral Tegmental Area | 2009 |